| Literature DB >> 34929567 |
Dafu Zhu1, Haixia Su2, Changqiang Ke3, Chunping Tang3, Matthias Witt4, Ronald J Quinn5, Yechun Xu6, Jia Liu7, Yang Ye8.
Abstract
The 3C-like protease (3CLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential to the virus life cycle and is supposed to be a potential target for the treatment of coronaviral infection. Traditional Chinese medicines (TCMs) have played an impressive role in the treatment of COVID-19 in China. The effectiveness of TCM formulations prompts scientists to take continuous effort on searching for bioactive small molecules from the ancient resources. Herein, we developed a native mass spectrometry-based affinity-selection method for rapid screening of active small molecules from crude herbal extracts applied for COVID-19 therapy. Six common herbs named Lonicera japonica, Scutellaria baicalensis, Forsythia suspensa, Glycyrrhiza uralensis, Cirsium japonicum, and Andrographis paniculata were investigated. After preliminary separation of the crude extracts, the fractions were incubated with 3CLpro. A native MS-based affinity screening assay was then conducted to search for the protein-ligand complexes. A UHPLC-Q/TOF-MS with UNIFI data acquisition and data processing software was applied to identify the hit compounds. Standard compounds were used to verify the outcomes. Among the 16 hits, three flavonoids, baicalein, scutellarein and ganhuangenin, were identified as potential noncovalent inhibitors against 3CLpro with IC50 values of 0.94, 3.02, and 0.84 μM, respectively. Their binding affinities were further characterized by native MS, with Kd values being 1.43, 3.85, and 1.09 μM, respectively. Overall, we established an efficient native MS-based strategy for discovering 3CLpro ligands from crude mixtures, which supplies a potential strategy of small molecule lead discovery from TCMs.Entities:
Keywords: 3CL protease; Native MS; Natural product; SARS-CoV-2; Traditional Chinese medicine
Mesh:
Substances:
Year: 2021 PMID: 34929567 PMCID: PMC8670146 DOI: 10.1016/j.jpba.2021.114538
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935
Fig. 1Spray condition optimization for 3CLpro. Raw MS spectra (A) and deconvoluted spectra (B) of 3CLpro mainly in dimer (dark blue) or monomer (light blue) states. (C) The intensity of 3CLpro in NH4Ac at different concentrations. (D) The intensity of 3CLpro in 10 mM NH4Ac at different pH values. The influence of different proportions of DMSO (E), MeOH (F), or ACN (G) on the spray system. Experiments were repeated at least three times. Bars represent mean ± SD.
Fig. 2Representative MS spectra of native MS-based affinity screening. (A) MS spectrum of apo-3CLpro during the screening process: 3CLpro mainly presents in charge states P19+ and P18+. (B) Representative MS spectrum of a negative result from fraction 1 of Andrographis paniculata. Representative MS spectra of two positive results from fraction 3 (C) and fraction 6 (D) of Andrographis paniculata. The protein-ligand binary complexes (P + L) were found distinctly and the Δm/z was used to calculate the molecular weight of the ligands. Later, andrographoside and andrographolide were identified in fraction 3 and fraction 6 as compounds 12 and 13, respectively.
The hit compounds identified from the TCMs.
| ID | Name | Chemotype | Source |
|---|---|---|---|
| 1 | Baicalin | Flavonoid | |
| 2 | Baicalein | Flavonoid | |
| 3 | Scutellarein | Flavonoid | |
| 4 | Ganhuangenin | Flavonoid | |
| 5 | Wogonoside | Flavonoid | |
| 6 | Oroxylin A-7-O-β- | Flavonoid | |
| 7 | Luteoloside | Flavonoid | |
| 8 | Forsythoside B | Phenylpropanoid | |
| 9-1 | Forsythoside A | Phenylpropanoid | |
| 9-2 | Forsythoside H | Phenylpropanoid | |
| 9-3 | Forsythoside I | Phenylpropanoid | |
| 9-4 | Isoforsythiaside | Phenylpropanoid | |
| 9-5 | Acteoside | Phenylpropanoid | |
| 10-1 | Chlorogenic acid | Phenylpropanoid | |
| 10-2 | Neochlorogenic acid | Phenylpropanoid | |
| 10-3 | Cryptochlorogenic acid | Phenylpropanoid | |
| 11-1 | Isochlorogenic acid A | Phenylpropanoid | |
| 11-2 | Isochlorogenic acid B | Phenylpropanoid | |
| 11-3 | Isochlorogenic acid C | Phenylpropanoid | |
| 12 | Andrographoside | Terpenoid | |
| 13 | Andrographolide | Terpenoid | |
| 14 | Liquiritin | Flavonoid | |
| 15 | Glycyrrhizic acid | Terpenoid | |
| 16 | Pectolinarin | Flavonoid |
Fig. 3The structure of the hit compounds.
Fig. 4Differences in binding selectivity observed by native MS. (A) MS spectrum of apo-3CLpro during the titration assay. 3CLpro mainly presents in charge states P19+ and P18+. (B) MS spectrum of 3CLpro incubated with compound 2. The peaks of protein-ligand complexes were represented by P + L. (C) MS spectrum of 3CLpro incubated with compound 9-1. Nonspecific binding occurred.
Fig. 5Evaluation of the hit compounds. (A–C) Inhibition curves for compounds 2, 3 and 4. (D–F) Binding affinities of compounds 2, 3, and 4 with SARS-CoV-2 3CLpro characterized by native MS. Fraction of ligand bound protein ([PL]/[P]t) obtained under optimized conditions plotted against total ligand concentrations. All data are shown as mean ± SD.
Binding affinity of compound 2, 3 and 4 with SARS-CoV-2 3CLpro determined by MRMS and the inhibition of 3CLpro by the three compounds.
| ID | Name | IC50 (μM) | Bmax | |
|---|---|---|---|---|
| 2 | Baicalein | 0.94 ± 0.20 | 1.43 ± 0.15 | 1.02 ± 0.02 |
| 3 | Scutellarein | 3.02 ± 0.11 | 3.85 ± 0.47 | 0.88 ± 0.02 |
| 4 | Ganhuangenin | 0.84 ± 0.06 | 1.09 ± 0.14 | 1.11 ± 0.01 |